<table id="ifaef9cff-d437-4536-865e-fc60f10c19fe" width="80%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (<linkhtml href="#S2.6">2.6</linkhtml>, <linkhtml href="#S5.1">5.1</linkhtml>, <linkhtml href="#S7">7</linkhtml>, <linkhtml href="#S12.3">12.3</linkhtml>)</caption>
<col align="left" valign="middle" width="50%"></col>
<col align="left" valign="middle" width="50%"></col>
<thead>
<tr>
<th stylecode="Lrule Rrule">Interacting Agents</th>
<th stylecode="Rrule">Prescribing Recommendations</th>
</tr>
</thead>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Cyclosporine, HIV protease inhibitors (tipranavir plus ritonavir), hepatitis C protease inhibitor (telaprevir)</td>
<td stylecode="Rrule">Avoid atorvastatin</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">HIV protease inhibitor (lopinavir plus ritonavir)</td>
<td stylecode="Rrule">Use with caution and lowest dose necessary</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Clarithromycin, itraconazole, HIV protease inhibitors (saquinavir plus ritonavir, darunavir plus ritonavir, fosamprenavir, fosamprenavir plus ritonavir)</td>
<td stylecode="Rrule">Do not exceed 20 mg atorvastatin daily</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">HIV protease inhibitor (nelfinavir)<br/>Hepatitis C protease inhibitor (boceprevir)</td>
<td stylecode="Rrule">Do not exceed 40 mg atorvastatin daily</td>
</tr>
</tbody>
</table>